WallStreetZenWallStreetZen

NASDAQ: LPTX
Leap Therapeutics Inc Stock Ownership - Who owns Leap Therapeutics?

Insider buying vs selling

Have Leap Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LPTX insiders and whales buy or sell their stock.

LPTX Shareholders

What type of owners hold Leap Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC22.15%8,476,496$17.55MInsider
Beigene Ltd19.20%7,348,437$15.21MInsider
Augustine Lawlor17.00%6,503,197$13.46MInsider
Christopher Mirabelli16.31%6,241,357$12.92MInsider
Gilead Sciences Inc13.90%5,319,148$11.01MInsider
Healthcare Ventures Ix LP10.83%4,144,804$8.58MInsider
Douglas E. Onsi9.65%3,691,511$7.64MInsider
James H. Cavanaugh6.84%2,618,406$5.42MInsider
John W. Littlechild6.84%2,618,406$5.42MInsider
Lilly Co Eli3.87%1,479,307$3.06MInsider

1 of 3

LPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LPTX14.38%85.62%
TLSA0.79%0.00%
MIST58.85%24.11%
VANI4.37%95.63%Net Buying
ELTX3.96%92.23%Net Buying

Leap Therapeutics Stock Ownership FAQ

Who owns Leap Therapeutics?

Leap Therapeutics (NASDAQ: LPTX) is owned by 21.27% institutional shareholders, 126.62% Leap Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Leap Therapeutics shareholder, owning 8.48M shares representing 22.15% of the company. Perceptive Advisors LLC's Leap Therapeutics shares are currently valued at $16.44M.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.